147 related articles for article (PubMed ID: 1546121)
1. Efficacy and tolerability of moclobemide compared with fluvoxamine in depressive disorder (DSM III). A French/Swiss double-blind trial.
Bougerol T; Uchida C; Gachoud JP; Köhler M; Mikkelsen H
Psychopharmacology (Berl); 1992; 106 Suppl():S102-8. PubMed ID: 1546121
[TBL] [Abstract][Full Text] [Related]
2. [Multicenter study comparing efficacy and tolerance of moclobemide and fluvoxamine in hospitalized and ambulatory patients with severe depressive episodes].
Barrelet L; Blajev B; Bolzani L; de Saussure C; Kasas A; Van H; Gachoud JP
Schweiz Rundsch Med Prax; 1991 May; 80(19):524-8. PubMed ID: 1904620
[TBL] [Abstract][Full Text] [Related]
3. Moclobemide twice daily in the treatment of major depressive episode: a double-blind, multicenter comparison with different three times daily dosage schedules.
Gagiano CA; Müller FG; Berk M; Joubert PM; Brown RG; Schall R
J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):4S-9S. PubMed ID: 7593729
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the efficacy and tolerability of moclobemide given as a single daily dose or in three divided doses per day for the treatment of patients with a major depressive episode (DSM-III-R).
Newburn G; Edwards R; Thomas H; Collier J; Fox K; Collins C; Cramer D; Reeves J; Caracatsanis A
J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):10S-15S. PubMed ID: 7593724
[TBL] [Abstract][Full Text] [Related]
5. Moclobemide twice daily in the treatment of major depressive episode: a double-blind, multicenter comparison with different three-times-daily dosage schedules.
Gagiano CA; Hart GA; Bodemer W; Schall R
Clin Neuropharmacol; 1994; 17 Suppl 1():S1-8. PubMed ID: 7954480
[TBL] [Abstract][Full Text] [Related]
6. Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
Lapierre YD; Joffe R; McKenna K; Bland R; Kennedy S; Ingram P; Reesal R; Rickhi BG; Beauclair L; Chouinard G; Annable L
J Psychiatry Neurosci; 1997 Mar; 22(2):118-26. PubMed ID: 9074306
[TBL] [Abstract][Full Text] [Related]
7. Multicenter double-blind study of moclobemide and maprotiline.
Vaz-Serra A; Figueira ML; Firmino H; Albuquerque AJ; Jara JM; Pestana LC
Clin Neuropharmacol; 1994; 17 Suppl 1():S38-49. PubMed ID: 7954483
[TBL] [Abstract][Full Text] [Related]
8. Moclobemide versus fluoxetine for major depressive episodes.
Geerts S; Bruynooghe F; De Cuyper H; Demeulemeester F; Haazen L
Clin Neuropharmacol; 1994; 17 Suppl 1():S50-7. PubMed ID: 7954484
[TBL] [Abstract][Full Text] [Related]
9. A multicentre comparative trial of moclobemide, imipramine and placebo in major depressive disorder. UK Moclobemide Study Group.
Int Clin Psychopharmacol; 1994; 9(2):109-13. PubMed ID: 8056992
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and tolerability of moclobemide and maprotiline in depressed patients treated by general practitioners.
Gachoud JP; Dick P; Köhler M
Clin Neuropharmacol; 1994; 17 Suppl 1():S29-37. PubMed ID: 7954482
[TBL] [Abstract][Full Text] [Related]
11. Moclobemide versus fluoxetine for a major depressive episode.
Reynaert C; Parent M; Mirel J; Janne P; Haazen L
Psychopharmacology (Berl); 1995 Mar; 118(2):183-7. PubMed ID: 7617806
[TBL] [Abstract][Full Text] [Related]
12. Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial.
Roth M; Mountjoy CQ; Amrein R
Br J Psychiatry; 1996 Feb; 168(2):149-57. PubMed ID: 8837903
[TBL] [Abstract][Full Text] [Related]
13. Moclobemide and nortriptyline in elderly depressed patients. A randomized, multicentre trial against placebo.
Nair NP; Amin M; Holm P; Katona C; Klitgaard N; Ng Ying Kin NM; Kragh-Sørensen P; Kühn H; Leek CA; Stage KB
J Affect Disord; 1995 Jan; 33(1):1-9. PubMed ID: 7714303
[TBL] [Abstract][Full Text] [Related]
14. Moclobemide and placebo in mild major depression: a double-blind randomized trial.
Ose E; Holm P
Psychopharmacology (Berl); 1992; 106 Suppl():S114-5. PubMed ID: 1546122
[TBL] [Abstract][Full Text] [Related]
15. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
Orsel Donbak S; Turkçapar MH; Ozturk Kiliç EZ; Demirergi N; Akdemir A; Sirin A; Ozbay MH
Acta Psychiatr Belg; 1995; 95(3):139-51. PubMed ID: 8525856
[TBL] [Abstract][Full Text] [Related]
16. Moclobemide versus fluoxetine for double depression: a randomized double-blind study.
Duarte A; Mikkelsen H; Delini-Stula A
J Psychiatr Res; 1996; 30(6):453-8. PubMed ID: 9023788
[TBL] [Abstract][Full Text] [Related]
17. A double-blind comparison of moclobemide and toloxatone in out-patients presenting a major depressive disorder.
Lemoine P; Mirabaud C
Psychopharmacology (Berl); 1992; 106 Suppl():S118-9. PubMed ID: 1546124
[TBL] [Abstract][Full Text] [Related]
18. Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial.
Guelfi JD; Payan C; Fermanian J; Pedarriosse AM; Manfredi R
Br J Psychiatry; 1992 Apr; 160():519-24. PubMed ID: 1571752
[TBL] [Abstract][Full Text] [Related]
19. A double-blind comparison of moclobemide and amineptine in the treatment of depressed out-patients.
Macher JP; Mirabaud C
Psychopharmacology (Berl); 1992; 106 Suppl():S116-7. PubMed ID: 1546123
[TBL] [Abstract][Full Text] [Related]
20. A double blind trial of moclobemide versus amitriptyline in the treatment of depressive disorders.
Newburn GM; Fraser AR; Menkes DB; Mullen PE
Aust N Z J Psychiatry; 1990 Dec; 24(4):475-9. PubMed ID: 2073222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
